MedTrace Logo

Intralesional Treatment of Keloids

NCT06729840 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-12-11

No results posted yet for this study

Summary

Intralesional injection in treatment of keloid

Conditions

  • Scar, Hypertrophic

Interventions

DRUG

Injection

Vitamin D , botox , tramcinolone intralesionally injected in keloid

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-04-01
Completion
2025-05-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06729840 on ClinicalTrials.gov